Category: 3D Biology

Q&A with Dr. Sergio Rutella: Multi-analyte studies in acute myeloid leukemia

Sergio Rutella, M.D., Ph.D. FRCPath is a Professor of Cancer Immunotherapy at the John van Geest Cancer Research Centre at Nottingham Trent University. His research focuses on acute myeloid leukemia (AML), an aggressive form of cancer that originates in the...

/ December 14, 2017

Q&A with Dr. David Coffey, FHCRC: Multi-analyte studies in multiple myeloma and lymphoma

David Coffey, MD, is a physician scientist with the Fred Hutchinson Cancer Research Center in Seattle, Washington. When he’s not treating patients, he’s in the lab researching blood cancers such as multiple myeloma and lymphoma. His research centers on the...

/ November 16, 2017

Moving Toward the Clinic- Leveraging Xenograft Models for Preclinical Anti-Cancer Studies

The use of cancer cell lines for in vitro studies of anti-cancer agents remains a primary component of preclinical drug development. These studies, however, struggle with significant pitfalls given the unique biology of cancer cell lines and the artificial assay...

/ November 2, 2017
3D-Bio_prison-01_blog

Taking off the Blinders- The Acceleration of Integrated Multi-omic Analysis

Typically our fields require us to specialize; geneticists profile DNA and RNA, flow cytometrists look at extracellular protein markers, and system biologists look at complex data from six different instruments. We often stay in our single-omic lane, only deviating when absolute necessity...

/ October 18, 2017

Getting More from Flow Cytometry

Immunology studies rely on identifying unique cell populations, such as T cells and B cells, and then analyzing these cells to understand the biology of these cells. Studying different types of immune cells has provided insight into many fields, such...

/ October 2, 2017